With regard to inflammatory biomarkers, both patients with RA and PD exhibit high levels of IL1β, IL6, MMPs and TNF-α, and the increased expression of pro-inflammatory cytokines can stimulate STAT3 activation and play an essential role in the pathophysiology of RA and PD (29). The gene discussed is IL6; the disease is rheumatoid arthritis.